A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients

Despite the promising therapeutic effects of immune checkpoint blockade (ICB), most patients with solid tumors treated with anti-PD-1/PD-L1 monotherapy do not achieve objective responses, with most tumor regressions being partial rather than complete. It is hypothesized that the absence of pre-exist...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Front Immunol
Główni autorzy: Bassani-Sternberg, Michal, Digklia, Antonia, Huber, Florian, Wagner, Dorothea, Sempoux, Christine, Stevenson, Brian J., Thierry, Anne-Christine, Michaux, Justine, Pak, HuiSong, Racle, Julien, Boudousquie, Caroline, Balint, Klara, Coukos, George, Gfeller, David, Martin Lluesma, Silvia, Harari, Alexandre, Demartines, Nicolas, Kandalaft, Lana E.
Format: Artigo
Język:Inglês
Wydane: Frontiers Media S.A. 2019
Hasła przedmiotowe:
Immunology
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6694698/
https://ncbi.nlm.nih.gov/pubmed/31440238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01832
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy